Skip to main content

Table 1 Clinicopathologic characteristics of studied population (n = 123)

From: Prognostic utility of epidermal growth factor receptor (EGFR) expression in prostatic acinar adenocarcinoma

   n(%)
Age(years)
 Mean ± SD   69.05 ± 8.68
 Mean follow up time (months)   21.67 + 12.56
Age Groups
  ≤70 years 77(62.6)
  > 70 years 46(37.4)
Tumor quantification (%)
 Mean ± SD   49.83 ± 30.53
Groups
  < 10% 23(18.7)
  10–50% 35(28.5)
  > 50% 65(52.8)
Total gleason score 6 39(31.7)
7 29(23.6)
8 27(22)
9 28(22.8)
WHO grade group Grade 1 39(31.7)
Grade 2 25(20.3)
Grade 3 4(3.3)
Grade 4 27(22)
Grade 5 28(22.8)
Perineural invasion Present 46(37.4)
Absent 77(62.6)
Lymphovascular invasion Present 3(2.4)
Absent 120 (97.6)
Extraprostatic extension Present 7(5.7)
Absent 116(94.3)
Seminal vesicle invasion Present 4(3.3)
Absent 119(96.7)
Specimen type Radical prostatectomy 18(14.6)
TURP 105(85.4)
Recurrence duration (months)   9.39 ± 3.22
Recurrence Yes 33(26.8)
No 90(73.2)
EFGR expression Positive 23(18.7)
Negative 100(81.3)
Her2 neu Positive 28(22.8)
Negative 95(77.2)